Nugene International Stock Probability of Future Pink Sheet Price Finishing Over 0.00252
| NUGN Stock | USD 0 0.0009 22.50% |
NuGene |
NuGene International Target Price Odds to finish over 0.00252
The tendency of NuGene Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 0 in 90 days |
| 0 | 90 days | 0 | close to 99 |
Based on a normal probability distribution, the odds of NuGene International to stay above $ 0 in 90 days from now is close to 99 (This NuGene International probability density function shows the probability of NuGene Pink Sheet to fall within a particular range of prices over 90 days) . Probability of NuGene International price to stay between $ 0 and its current price of $0.0049 at the end of the 90-day period is about 6.69 .
Given the investment horizon of 90 days NuGene International has a beta of -2.05. This indicates as returns on its benchmark rise, returns on holding NuGene International are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, NuGene International is expected to outperform its benchmark. Additionally NuGene International has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. NuGene International Price Density |
| Price |
Predictive Modules for NuGene International
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as NuGene International. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.NuGene International Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. NuGene International is not an exception. The market had few large corrections towards the NuGene International's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold NuGene International, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of NuGene International within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.35 | |
β | Beta against Dow Jones | -2.05 | |
σ | Overall volatility | 0 | |
Ir | Information ratio | -0.06 |
NuGene International Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of NuGene International for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for NuGene International can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| NuGene International generated a negative expected return over the last 90 days | |
| NuGene International has high historical volatility and very poor performance | |
| NuGene International has some characteristics of a very speculative penny stock | |
| NuGene International has a very high chance of going through financial distress in the upcoming years | |
| NuGene International currently holds 2.8 M in liabilities with Debt to Equity (D/E) ratio of 1.05, which is about average as compared to similar companies. NuGene International has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist NuGene International until it has trouble settling it off, either with new capital or with free cash flow. So, NuGene International's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NuGene International sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NuGene to invest in growth at high rates of return. When we think about NuGene International's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 1.47 M. Net Loss for the year was (75.19 K) with loss before overhead, payroll, taxes, and interest of (209.4 K). | |
| NuGene International currently holds about 118.34 K in cash with (2 M) of positive cash flow from operations. |
NuGene International Technical Analysis
NuGene International's future price can be derived by breaking down and analyzing its technical indicators over time. NuGene Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NuGene International. In general, you should focus on analyzing NuGene Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
NuGene International Predictive Forecast Models
NuGene International's time-series forecasting models is one of many NuGene International's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary NuGene International's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about NuGene International
Checking the ongoing alerts about NuGene International for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for NuGene International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| NuGene International generated a negative expected return over the last 90 days | |
| NuGene International has high historical volatility and very poor performance | |
| NuGene International has some characteristics of a very speculative penny stock | |
| NuGene International has a very high chance of going through financial distress in the upcoming years | |
| NuGene International currently holds 2.8 M in liabilities with Debt to Equity (D/E) ratio of 1.05, which is about average as compared to similar companies. NuGene International has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist NuGene International until it has trouble settling it off, either with new capital or with free cash flow. So, NuGene International's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NuGene International sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NuGene to invest in growth at high rates of return. When we think about NuGene International's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 1.47 M. Net Loss for the year was (75.19 K) with loss before overhead, payroll, taxes, and interest of (209.4 K). | |
| NuGene International currently holds about 118.34 K in cash with (2 M) of positive cash flow from operations. |
Other Information on Investing in NuGene Pink Sheet
NuGene International financial ratios help investors to determine whether NuGene Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NuGene with respect to the benefits of owning NuGene International security.